SCHEMBL19080136

SCHEMBL19080136

c1ccc(-c2cc(-c3c4ccccc4c(-c4cccc(-c5ccc6c7ccccc7c7c8cc9ccccc9cc8oc7c6c5)c4)c4ccccc34)c3ccccc3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
MPI P34949 1/20 0.32
KMT2A Q03164 1/20 0.32
GPR84 Q9NQS5 3/20 0.31
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
PLA2G10 O15496 1/20 0.31
ESR1 P03372 3/20 0.30
ESR2 Q92731 3/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2B6 P20813 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079976 0.90 PSD (0.34) KDM4EALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL19079940 0.90 ESR1 (0.38) HSD17B1HSD17B2KDM4EMEN1ALDH1A1
SCHEMBL19080009 0.89 CYP1A1 (0.37) HSD17B1HSD17B2KDM4EALDH1A1MAPT
SCHEMBL19080134 0.87 ABCG2 (0.37) HSD17B1HSD17B2KDM4EALDH1A1MAPT
SCHEMBL19080120 0.87 CA12 (0.37) ESR1ESR2CYP2C9CYP2C19
SCHEMBL19080071 0.85 SOS1 (0.34) KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL19080040 0.84 ESR1 (0.37) HSD17B1HSD17B2KDM4EMEN1ALDH1A1
SCHEMBL17944230 0.84 HSD17B1 (0.39) HSD17B1HSD17B2KDM4EMEN1ALDH1A1
SCHEMBL17944227 0.84 KDM4E (0.35) HSD17B1HSD17B2KDM4EMEN1ALDH1A1
SCHEMBL19079943 0.84 ESR1 (0.38) KDM4EMEN1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 HSD17B1 733/4885HSD17B2 953/4885KDM4E 3545/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 HSD17B1 733/4885HSD17B2 953/4885KDM4E 3545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.